User profiles for Julie A. Ake
 | Julie A. AkeDirector, US Military HIV Research Program Verified email at mail.mil Cited by 3984 |
[HTML][HTML] Efficacy and safety of NVX-CoV2373 in adults in the United States and Mexico
…, AL Greninger, J Hutter, JA Ake… - … England Journal of …, 2022 - Mass Medical Soc
Background NVX-CoV2373 is an adjuvanted, recombinant spike protein nanoparticle vaccine
that was shown to have clinical efficacy for the prevention of coronavirus disease 2019 (…
that was shown to have clinical efficacy for the prevention of coronavirus disease 2019 (…
Relative Nephroprotection During Escherichia coli O157:H7 Infections: Association With Intravenous Volume Expansion
Objective. The hemolytic uremic syndrome (HUS) consists of hemolytic anemia, thrombocytopenia,
and renal failure. HUS is often precipitated by gastrointestinal infection with Shiga …
and renal failure. HUS is often precipitated by gastrointestinal infection with Shiga …
[HTML][HTML] Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial
…, L Corey, KM Neuzil, D Follmann, JA Ake… - Nature …, 2023 - nature.com
In the PREVENT-19 phase 3 trial of the NVX-CoV2373 vaccine (NCT04611802), anti-spike
binding IgG concentration (spike IgG), anti-RBD binding IgG concentration (RBD IgG), and …
binding IgG concentration (spike IgG), anti-RBD binding IgG concentration (RBD IgG), and …
Current approaches to HIV vaccine development: a narrative review
Introduction The development of an effective vaccine to protect against HIV is a longstanding
global health need complicated by challenges inherent to HIV biology and to the execution …
global health need complicated by challenges inherent to HIV biology and to the execution …
Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in …
…, RA Koup, JR Mascola, A Ploquin, NJ Sullivan, JA Ake… - The Lancet, 2023 - thelancet.com
Background WHO has identified Marburg virus as an emerging virus requiring urgent vaccine
research and development, particularly due to its recent emergence in Ghana. We report …
research and development, particularly due to its recent emergence in Ghana. We report …
[HTML][HTML] HIV virologic failure and its predictors among HIV-infected adults on antiretroviral therapy in the African Cohort Study
Introduction The 2016 WHO consolidated guidelines on the use of antiretroviral drugs defines
HIV virologic failure for low and middle income countries (LMIC) as plasma HIV-RNA ≥ …
HIV virologic failure for low and middle income countries (LMIC) as plasma HIV-RNA ≥ …
[HTML][HTML] Effect of HIV infection and antiretroviral therapy on immune cellular functions
…, M Byrne, E Richter, BT Schultz, P Juszczak, JA Ake… - JCI insight, 2019 - ncbi.nlm.nih.gov
During chronic HIV infection, immune cells become increasingly dysfunctional and exhausted.
Little is known about how immune functions are restored after initiation of antiretroviral …
Little is known about how immune functions are restored after initiation of antiretroviral …
[HTML][HTML] Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo …
…, DH Barouch, H Schuitemaker, F Tomaka, JA Ake… - The Lancet …, 2020 - thelancet.com
Background Bioinformatically designed mosaic antigens increase the breadth of HIV
vaccine-elicited immunity. This study compared the safety, tolerability, and immunogenicity of a …
vaccine-elicited immunity. This study compared the safety, tolerability, and immunogenicity of a …
Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial
…, ML Robb, N Phanuphak, J Ananworanich, JA Ake… - The lancet HIV, 2019 - thelancet.com
Background HIV-1-specific broadly neutralising antibodies such as VRC01 could promote
HIV remission by halting viral replication and clearing infected cells. We investigated whether …
HIV remission by halting viral replication and clearing infected cells. We investigated whether …
PEPFAR's response to the convergence of the HIV and COVID‐19 pandemics in Sub‐Saharan Africa
Introduction: The COVID-19 pandemic reached the African continent in less than three
months from when the first cases were reported from mainland China. As COVID-19 …
months from when the first cases were reported from mainland China. As COVID-19 …
